Published in J Virol on April 01, 1995
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Adeno-associated virus vector integration junctions. J Virol (1997) 2.03
Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol (1997) 1.72
The Rep78 gene product of adeno-associated virus (AAV) self-associates to form a hexameric complex in the presence of AAV ori sequences. J Virol (1997) 1.63
Adeno-associated virus: from defective virus to effective vector. Virol J (2005) 1.60
Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol (1999) 1.55
Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J Virol (1999) 1.49
Sequences from ancestral single-stranded DNA viruses in vertebrate genomes: the parvoviridae and circoviridae are more than 40 to 50 million years old. J Virol (2010) 1.38
Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J Virol (2000) 1.37
Site-specific integration of adeno-associated virus involves partial duplication of the target locus. Proc Natl Acad Sci U S A (2009) 1.35
A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci U S A (2002) 1.31
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol (1998) 1.28
Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J Virol (1997) 1.25
Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity. J Virol (1997) 1.24
Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase. J Virol (2009) 1.24
Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. J Virol (2002) 1.21
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat. Proc Natl Acad Sci U S A (2001) 1.21
Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Mol Cell Biol (1998) 1.20
The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol (2009) 1.19
Mechanism of Rep-mediated adeno-associated virus origin nicking. J Virol (2000) 1.17
Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J Virol (2001) 1.16
An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA. J Virol (2000) 1.16
Binding sites for adeno-associated virus Rep proteins within the human genome. J Virol (1997) 1.13
A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J Virol (1997) 1.13
Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol (2008) 1.12
Characteristics of the adeno-associated virus preintegration site in human chromosome 19: open chromatin conformation and transcription-competent environment. J Virol (2000) 1.12
Comparative characterization of rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. J Virol (1999) 1.11
Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J Virol (1999) 1.10
Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro. J Virol (2001) 1.09
DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. J Virol (2000) 1.07
Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. J Virol (2000) 1.06
Development of animal models for adeno-associated virus site-specific integration. J Virol (1999) 1.04
Adeno-associated virus: a key to the human genome? Future Virol (2010) 1.03
Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proc Natl Acad Sci U S A (1999) 1.02
Adeno-associated virus site-specific integration and AAVS1 disruption. J Virol (2004) 1.00
The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element. J Virol (2005) 0.98
Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production. J Virol (2003) 0.98
High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration. J Virol (2013) 0.97
A cis-acting element that directs circular adeno-associated virus replication and packaging. J Virol (2002) 0.96
Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins. J Virol (1999) 0.95
Replication initiator protein NS1 of the parvovirus minute virus of mice binds to modular divergent sites distributed throughout duplex viral DNA. J Virol (2007) 0.93
Characterization of the mouse adeno-associated virus AAVS1 ortholog. J Virol (2004) 0.92
Selective cleavage of AAVS1 substrates by the adeno-associated virus type 2 rep68 protein is dependent on topological and sequence constraints. J Virol (2000) 0.92
Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro. J Virol (1999) 0.90
The putative metal coordination motif in the endonuclease domain of human Parvovirus B19 NS1 is critical for NS1 induced S phase arrest and DNA damage. Int J Biol Sci (2011) 0.90
Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric Interface. J Virol (2016) 0.90
Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein. J Virol (2000) 0.88
Directed integration of minute virus of mice DNA into episomes. J Virol (1997) 0.87
Preferential integration of adeno-associated virus type 2 into a polypyrimidine/polypurine-rich region within AAVS1. J Virol (2007) 0.86
Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter. J Virol (1998) 0.85
Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19. J Virol (2005) 0.84
Adeno-associated virus type 2 p5 promoter: a rep-regulated DNA switch element functioning in transcription, replication, and site-specific integration. J Virol (2007) 0.81
Adeno-associated virus site-specific integration is regulated by TRP-185. J Virol (2006) 0.80
Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter. J Virol (2014) 0.79
Transcriptional analysis of the adeno-associated virus integration site. J Virol (2009) 0.79
Substitution of adeno-associated virus Rep protein binding and nicking sites with human chromosome 19 sequences. Virol J (2010) 0.78
Highly divergent integration profile of adeno-associated virus serotype 5 revealed by high-throughput sequencing. J Virol (2013) 0.77
Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints. Virol J (2014) 0.77
Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer. PLoS One (2013) 0.77
Structural Studies of AAV2 Rep68 Reveal a Partially Structured Linker and Compact Domain Conformation. Biochemistry (2015) 0.76
The persistence of alien genomes. Proc Natl Acad Sci U S A (2000) 0.75
p53 inhibits adeno-associated viral vector integration. Hum Gene Ther (2011) 0.75
Herpes simplex virus type 1/adeno-associated virus hybrid vectors. Open Virol J (2010) 0.75
The binding site on SV40 DNA for a T antigen-related protein. Cell (1978) 10.58
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Animal virus DNA replication. Annu Rev Biochem (1989) 6.41
Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol (1992) 6.16
Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell (1990) 5.98
Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells. Mol Cell Biol (1985) 5.83
Topography of simian virus 40 A protein-DNA complexes: arrangement of pentanucleotide interaction sites at the origin of replication. J Virol (1983) 5.00
Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature (1994) 4.96
Territorial limits and functional anatomy of the simian virus 40 replication origin. Proc Natl Acad Sci U S A (1982) 4.77
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 4.57
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J (1992) 4.36
Replication factors required for SV40 DNA replication in vitro. I. DNA structure-specific recognition of a primer-template junction by eukaryotic DNA polymerases and their accessory proteins. J Biol Chem (1991) 4.32
Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene (1983) 4.15
Simian virus 40 DNA replication in vitro: specificity of initiation and evidence for bidirectional replication. Mol Cell Biol (1985) 3.84
Localization of an origin of DNA replication within the TRS/IRS repeated region of the herpes simplex virus type 1 genome. EMBO J (1982) 3.61
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A (1994) 3.59
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics (1991) 3.47
Functional organization of the simian virus 40 origin of DNA replication. Mol Cell Biol (1986) 3.40
Parvovirus replication. Microbiol Rev (1990) 3.37
Herpes simplex virus DNA replication: the UL9 gene encodes an origin-binding protein. Proc Natl Acad Sci U S A (1988) 3.07
Essential contact residues within SV40 large T antigen binding sites I and II identified by alkylation-interference. Cell (1984) 2.59
Replication factors required for SV40 DNA replication in vitro. II. Switching of DNA polymerase alpha and delta during initiation of leading and lagging strand synthesis. J Biol Chem (1991) 2.51
Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol (1994) 2.32
Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J Virol (1993) 2.22
An enzyme system for replication of duplex circular DNA: the replicative form of phage phi X174. Proc Natl Acad Sci U S A (1976) 2.16
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol (1994) 1.98
Cotransformation and gene targeting in mouse embryonic stem cells. Mol Cell Biol (1991) 1.84
Adeno-associated virus rep proteins produced in insect and mammalian expression systems: wild-type and dominant-negative mutant proteins bind to the viral replication origin. Virology (1991) 1.84
In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. J Mol Biol (1991) 1.61
The role of the 70 kDa subunit of human DNA polymerase alpha in DNA replication. EMBO J (1993) 1.61
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
Adeno-associated virus vectors. Curr Opin Biotechnol (1992) 1.56
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
In vitro studies of the initiation of staphylococcal plasmid replication. Specificity of RepD for its origin (oriD) and characterization of the Rep-ori tyrosyl ester intermediate. J Biol Chem (1990) 1.53
DNA replication: enzymology and mechanisms. Curr Opin Genet Dev (1994) 1.14
Intergenic DNA and the sequence requirements for replication initiation in eukaryotes. Curr Opin Genet Dev (1994) 0.99
In vitro replication of DNA containing either the SV40 or the polyoma origin. Philos Trans R Soc Lond B Biol Sci (1987) 0.90
DNA replication in mammalian cells: insights from the SV40 model system. Harvey Lect (1991) 0.89
DNA replication and the cell cycle. Ciba Found Symp (1992) 0.83
Patient participation in decision-making. Soc Sci Med (1998) 8.05
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet (2000) 5.03
Assessment of the completeness and accuracy of computer medical records in four practices committed to recording data on computer. Br J Gen Pract (1995) 5.03
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell (1986) 4.72
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A (2000) 4.39
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA (2001) 4.38
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med (1999) 3.98
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet (1999) 3.61
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A (1994) 3.59
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother (2003) 3.24
Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med (2005) 3.21
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A (1985) 3.09
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol (2000) 3.00
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1992) 2.84
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
Management of traumatic intracranial haematoma. Br Med J (Clin Res Ed) (1982) 2.79
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc (2001) 2.67
Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci U S A (1986) 2.48
2B or not 2B: regulation of the catalytic utilization of eIF-2. Cell (1983) 2.32
Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol (1994) 2.32
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (1987) 2.31
Purification of the eukaryotic initiation factor 2-eukaryotic initiation factor 2B complex and characterization of its guanine nucleotide exchange activity during protein synthesis initiation. J Biol Chem (1983) 2.31
Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J (1987) 2.17
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Competition between cellular and viral mRNAs in vitro is regulated by a messenger discriminatory initiation factor. Proc Natl Acad Sci U S A (1976) 2.12
Evidence for role of m7G5'-phosphate group in recognition of eukaryotic mRNA by initiation factor IF-M3. Nature (1976) 2.09
Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol Cell Biol (1993) 2.05
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol (1994) 1.98
The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol (1989) 1.96
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
Purification and physical properties of homogeneous initiation factor MP from rabbit reticulocytes. J Biol Chem (1975) 1.83
Sequences of the coding and flanking regions of the large ribosomal subunit RNA gene of mosquito mitochondria. Nucleic Acids Res (1984) 1.82
Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol (1988) 1.77
Identification of the hypusine-containing protein hy+ as translation initiation factor eIF-4D. Proc Natl Acad Sci U S A (1983) 1.76
Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children. Paediatr Drugs (2001) 1.74
Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc Natl Acad Sci U S A (1975) 1.68
The Rep78 gene product of adeno-associated virus (AAV) self-associates to form a hexameric complex in the presence of AAV ori sequences. J Virol (1997) 1.63
The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity. J Virol (1998) 1.61
Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol (1986) 1.61
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol (1999) 1.55
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther (1995) 1.52
Binding and release of radiolabeled eukaryotic initiation factors 2 and 3 during 80 S initiation complex formation. J Biol Chem (1979) 1.50
The use of the laryngeal mask airway in primary anaesthesia. Anaesthesia (1990) 1.48
Factors involved in initiation of haemoglobin synthesis can be phosphorylated in vitro. Nature (1976) 1.47
Effect of hemin on site-specific phosphorylation of eukaryotic initiation factor 2. Proc Natl Acad Sci U S A (1978) 1.46
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein. J Virol (2000) 1.43
Mitochondrial-cytosolic interactions in perfused rat heart. Role of coupled transamination in repletion of citric acid cycle intermediates. J Biol Chem (1973) 1.41
Isolation of an active transcription initiation complex from HeLa cell-free extract. Proc Natl Acad Sci U S A (1984) 1.40
Oral oseltamivir in human experimental influenza B infection. Antivir Ther (2000) 1.39
Accuracy of a computer-based anaesthetic audit system. Anaesthesia (1993) 1.38
Retracted High rate of human papillomavirus type 16 infection in cytologically normal cervices. Lancet (1989) 1.38
The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers. J Clin Pharmacol (2000) 1.38
Purification and characterization of two initiation factors required for maximal activity of a highly fractionated globin mRNA translation system. Proc Natl Acad Sci U S A (1976) 1.36
Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun (2001) 1.34
Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J Virol (1995) 1.31
Comparative analysis of the exopolysaccharide biosynthesis gene clusters from four strains of Lactobacillus rhamnosus. Microbiology (2005) 1.29
Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. J Virol (2000) 1.28
Eukaryotic initiation complex formation. Evidence for two distinct pathways. J Biol Chem (1975) 1.27
Muscle fibre type changes in hypothyroid myopathy. J Clin Pathol (1975) 1.26
Regulation of adeno-associated virus DNA replication. Biochim Biophys Acta (1988) 1.26
Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26
Care management and mental health. BMJ (1993) 1.25
Regulation of gene expression for translation initiation factor eIF-2 alpha: importance of the 3' untranslated region. Biochem J (1996) 1.24
Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Neuropeptides (1991) 1.24
An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol Cell Biol (1986) 1.22
Morphological and biochemical studies of isolated mitochondria from fetal, neonatal, and adult liver and from neoplastic tissues. J Cell Biol (1967) 1.21
Role of eukaryotic initiation factor 5 in the formation of 80 S initiation complexes. J Biol Chem (1979) 1.21
Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Mol Cell Biol (1998) 1.20
Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques. Am J Pathol (1991) 1.19
Effect of rapid and conventional cooling methods on the quality of cooked ham joints. Meat Sci (2000) 1.18
Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. J Virol (2001) 1.16
An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA. J Virol (2000) 1.16
T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3. J Biol Chem (1996) 1.16
Oesophageal reflux after abdominal vagotomy. Lancet (1965) 1.15
Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus. J Med Genet (1984) 1.15
Analysis of initiation factor function in highly fractionated and unfractionated reticulocyte lysate systems. Methods Enzymol (1979) 1.14
Reduced activity of the interferon-induced double-stranded RNA-dependent protein kinase during a heat shock stress. J Biol Chem (1989) 1.14
Identification of a downstream sequence and binding protein that regulate adenovirus major late promoter transcription in vitro. J Biol Chem (1988) 1.13
Human papillomavirus subtype 16a. Lancet (1989) 1.13
Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry (1992) 1.13
Identification of a 48 S preinitiation complex in reticulocyte lysate. J Biol Chem (1978) 1.12
Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-alpha expression. Am J Physiol (1994) 1.11
Comparative characterization of rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. J Virol (1999) 1.11
Increased eIF-2 alpha expression in mitogen-activated primary T lymphocytes. EMBO J (1990) 1.11
Hypothyroid myopathy. A clinical and pathologaical study. J Pathol (1980) 1.11
Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol. Symp Soc Exp Biol (1973) 1.09